撤稿声明:COVID-19患者抗神经元自身抗体亚急性精神病经静脉免疫球蛋白治疗后缓解
本文是一篇撤稿声明,针对McAlpine等2021年发表在Biol Psychiatry的病例报告。因作者发现两份脑脊液样本被混淆,导致发表了错误的免疫染色数据,故应通讯作者要求撤稿。撤稿声明指出病例的临床特征准确且不受影响,但研究数据属于另一名COVID-19参与者;作者正在修订论文以供再次考虑发表。
要点
- 撤稿原因:两份脑脊液样本混淆,导致发表错误的免疫染色数据。
- 病例报告的临床特征准确且不受影响,但研究数据属于另一名患者。
- 作者正在修订论文,期刊将考虑再次发表。
核心结论
- 该病例报告因脑脊液样本混淆导致免疫染色数据错误而被撤稿,但临床特征准确且不受影响。
研究设计与样本
- 撤稿声明:针对Biol Psychiatry 2021年发表的病例报告,由通讯作者发起撤稿。
主要发现
- 作者发现两份脑脊液样本被混淆,导致发表了错误的COVID-19患者免疫染色数据。
- 两名盲法评估者确认脑脊液样本来自两名不同的COVID-19患者。
- 临床特征准确且不受影响,但研究数据属于另一名COVID-19研究参与者。
临床怎么用
- 临床医生应知晓该病例报告已撤稿,其研究数据不可靠,但临床特征仍准确。
- 该COVID-19精神病病例因对免疫治疗有明确反应仍具临床意义,作者正在修订论文。
局限性
- 撤稿声明未报告样本量、统计值或置信区间。
- 撤稿声明未提供修订版论文的具体内容或发表时间。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Retraction notice to: “Remission of Subacute Psychosis in a COVID-19 Patient With an Antineuronal Autoantibody After Treatment With Intravenous Immunoglobulin” by Lindsay S. McAlpine, Brooke Lifland, Joseph R. Check, Gustavo A. Angarita, Thomas T. Ngo, Samuel J. Pleasure, Michael R. Wilson, Serena S. Spudich, Shelli F. Farhadian, and Christopher M. Bartley (Biol Psychiatry 2021; 90:e23-e26); https://doi.org/10.1016/j.biopsych.2021.03.033. This article has been retracted at the request of corresponding author Christopher Bartley, with agreement from all authors and with approval from Biological Psychiatry Editor John H. Krystal, M.D. See Elsevier Policy on Article Withdrawal (http://www.elsevier.com/locate/withdrawalpolicy). After this article was published, the authors determined that two cerebrospinal fluid (CSF) samples were inadvertently confused, resulting in publication of the wrong COVID-19 patient’s immunostaining data. The authors determined that the two CSF samples came from COVID-19 patients with sequential case identifiers (i.e., one identifier ended in a “5” and the other in a “6”). To determine whether the published immunostaining results were produced by CSF from another COVID-19 patient, the authors reperformed the mouse brain immunostaining experiments using additional aliquots of stored CSF from the two research participants in question, as well as with the remaining CSF that had been used in the publication. After repeating the immunostaining with these CSF samples, two blinded raters were able to state unequivocally that the CSF samples from the two COVID-19 patients had been confused. Therefore, while the clinical features of the case report are accurate and unaffected, the research data belong to another COVID-19 research participant, not the one described in the published case report. The authors voluntarily informed the Journal of this honest error upon its discovery. All authors agree to retract this paper and sincerely apologize for having allowed the incorrect images to be published with this case report. To avoid misinterpretation of the research findings, both the editors and authors concur that the only proper course of action was to retract this version of the paper. However, this COVID-19 psychosis case remains of clinical interest because of the patient’s clear response to immunotherapy. Therefore, the authors are revising the paper, which the Journal will consider further for publication.
引用
- McAlpine LS, Lifland B, Check JR, et al. RETRACTED: Remission of Subacute Psychosis in a COVID-19 Patient With an Antineuronal Autoantibody After Treatment With Intravenous Immunoglobulin. Biol Psychiatry. 2021. PMID: 34001372. doi:10.1016/j.biopsych.2021.03.033
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。